Shopping Cart 0
Cart Subtotal
USD 0

Parexel International Corp - Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375

Details

Parexel International Corp-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

Parexel International Corp (Parexel), a subsidiary of Pamplona Capital Management LLP is a biopharmaceutical outsourcing service company. It provides services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Billerica, Massachusetts, the US.

Parexel International Corp Key Recent Developments

Aug 05,2019: Parexel appoints Gavin Nichols to lead informatics and information technology

Jul 23,2019: Parexel extends Asia/Pacific capability with the ;aunch of Health Advances Asia

Jun 23,2019: Parexel launches enhanced integrated functional service provider model to drive delivery of innovative clinical research partnerships

Jun 18,2019: Parexel strengthens risk-based monitoring offering with new advanced statistical capabilities

Jun 12,2019: Parexel teams with CLARINESS to enhance patient access and engagement in China

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Parexel International Corp-Key Facts

Parexel International Corp-Key Employees

Parexel International Corp-Key Employee Biographies

Parexel International Corp-Major Products and Services

Parexel International Corp-History

Parexel International Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Parexel International Corp-Business Description

Parexel International Corp-SWOT Analysis

SWOT Analysis-Overview

Parexel International Corp-Strengths

Parexel International Corp-Weaknesses

Parexel International Corp-Opportunities

Parexel International Corp-Threats

Parexel International Corp-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Parexel International Corp, Recent Deals Summary

Section 4-Company's Recent Developments

Aug 05, 2019: Parexel appoints Gavin Nichols to lead informatics and information technology

Jul 23, 2019: Parexel extends Asia/Pacific capability with the ;aunch of Health Advances Asia

Jun 23, 2019: Parexel launches enhanced integrated functional service provider model to drive delivery of innovative clinical research partnerships

Jun 18, 2019: Parexel strengthens risk-based monitoring offering with new advanced statistical capabilities

Jun 12, 2019: Parexel teams with CLARINESS to enhance patient access and engagement in China

Jun 03, 2019: Parexel appoints Dr. Makoto Sugita to lead its Japan organization

May 29, 2019: Parexel unveils Oncology Center of Excellence to support acceleration of patient-focused oncology drug development

Feb 27, 2019: PAREXEL Expands Oncology Expertise Through FDA and Medical Oncologist Appointments

Feb 12, 2019: PAREXEL names former FDA senior executives to global Regulatory Consulting services

Jan 28, 2019: PAREXEL receives consecutive recognitions from Forbes and FlexJobs for its workplace culture

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Parexel International Corp, Key Facts

Parexel International Corp, Key Employees

Parexel International Corp, Key Employee Biographies

Parexel International Corp, Major Products and Services

Parexel International Corp, History

Parexel International Corp, Other Locations

Parexel International Corp, Subsidiaries

Parexel International Corp, Key Competitors

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Parexel International Corp, Recent Deals Summary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Parexel International Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Pharmaceutical Product Development LLC

Quintiles Transnational Corp

Covance Inc

Veeva Systems Inc

Syneos Health NC LLC

ICON Plc

Worldwide Clinical Trials Drug Development Solutions Inc

Patheon NV

Laboratory Corp of America Holdings

inVentiv Health Inc

IQVIA Holdings Inc

Parexel International Corp-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

Parexel International Corp (Parexel), a subsidiary of Pamplona Capital Management LLP is a biopharmaceutical outsourcing service company. It provides services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Billerica, Massachusetts, the US.

Parexel International Corp Key Recent Developments

Aug 05,2019: Parexel appoints Gavin Nichols to lead informatics and information technology

Jul 23,2019: Parexel extends Asia/Pacific capability with the ;aunch of Health Advances Asia

Jun 23,2019: Parexel launches enhanced integrated functional service provider model to drive delivery of innovative clinical research partnerships

Jun 18,2019: Parexel strengthens risk-based monitoring offering with new advanced statistical capabilities

Jun 12,2019: Parexel teams with CLARINESS to enhance patient access and engagement in China

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Parexel International Corp-Key Facts

Parexel International Corp-Key Employees

Parexel International Corp-Key Employee Biographies

Parexel International Corp-Major Products and Services

Parexel International Corp-History

Parexel International Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Parexel International Corp-Business Description

Parexel International Corp-SWOT Analysis

SWOT Analysis-Overview

Parexel International Corp-Strengths

Parexel International Corp-Weaknesses

Parexel International Corp-Opportunities

Parexel International Corp-Threats

Parexel International Corp-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Parexel International Corp, Recent Deals Summary

Section 4-Company's Recent Developments

Aug 05, 2019: Parexel appoints Gavin Nichols to lead informatics and information technology

Jul 23, 2019: Parexel extends Asia/Pacific capability with the ;aunch of Health Advances Asia

Jun 23, 2019: Parexel launches enhanced integrated functional service provider model to drive delivery of innovative clinical research partnerships

Jun 18, 2019: Parexel strengthens risk-based monitoring offering with new advanced statistical capabilities

Jun 12, 2019: Parexel teams with CLARINESS to enhance patient access and engagement in China

Jun 03, 2019: Parexel appoints Dr. Makoto Sugita to lead its Japan organization

May 29, 2019: Parexel unveils Oncology Center of Excellence to support acceleration of patient-focused oncology drug development

Feb 27, 2019: PAREXEL Expands Oncology Expertise Through FDA and Medical Oncologist Appointments

Feb 12, 2019: PAREXEL names former FDA senior executives to global Regulatory Consulting services

Jan 28, 2019: PAREXEL receives consecutive recognitions from Forbes and FlexJobs for its workplace culture

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Parexel International Corp, Key Facts

Parexel International Corp, Key Employees

Parexel International Corp, Key Employee Biographies

Parexel International Corp, Major Products and Services

Parexel International Corp, History

Parexel International Corp, Other Locations

Parexel International Corp, Subsidiaries

Parexel International Corp, Key Competitors

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Parexel International Corp, Recent Deals Summary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Parexel International Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Pharmaceutical Product Development LLC

Quintiles Transnational Corp

Covance Inc

Veeva Systems Inc

Syneos Health NC LLC

ICON Plc

Worldwide Clinical Trials Drug Development Solutions Inc

Patheon NV

Laboratory Corp of America Holdings

inVentiv Health Inc

IQVIA Holdings Inc